ARCHIVES

Report calls for stronger peer review, prioritization for cancer clinical trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 23 | June 10, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

New Jersey Insurers To Cover Patient Care Costs In Trials.

January 14, 2000

HHS Proposes Six New DRGs for Leukemia, Lymphoma

July 4, 1986

Source Identified for Hepatitis A Contamination of LAK-IL-2 Trials; Six MIs Seen; Rosenberg Updates Intramural Results

October 24, 1986

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

November 29, 1991